EnteroMedics’ CEO Discusses Q1 2014 Results – Earnings Call Transcript

EnteroMedics’ CEO Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Greg Lea Thank you, Mark. For the three months ended March 31, 2014, the Company reported a net loss of 6.7 million, or a $0.10 per share. Research and development expenses were 2.6 million and general … more

View todays social media effects on ETRM

View the latest stocks trending across Twitter. Click to view dashboard

See who EnteroMedics is hiring next, click here to view

Share this post